Sakorafas G H, Sarr M G, Farley D R, Que F G, Andrews J C, Farnell M B
Department of Surgery, Mayo Clinic and Mayo Foundation, Rochester, MN 55902, USA.
Langenbecks Arch Surg. 2000 Mar;385(2):124-8. doi: 10.1007/s004230050254.
Hemosuccus pancreaticus, a rare form of upper gastrointestinal bleeding, may complicate chronic pancreatitis and pose a significant diagnostic and therapeutic dilemma.
To present our experience with this potentially life-threatening complication of chronic pancreatitis.
We reviewed our experience with management (both operative as well as angiographic embolization) of patients with hemosuccus pancreaticus complicating histologically documented chronic pancreatitis between 1976 and 1997. Diagnosis of hemosuccus pancreaticus was based on clinical presentation, preoperative endoscopic and radiographic imaging, operative findings, and pathologic evaluation.
During the period, we managed eight patients with hemosuccus pancreaticus (1.5% of all patients with chronic pancreatitis treated surgically). Gastrointestinal bleeding presented as hematemesis in three and hematochezia in three, but all had recent melena and were anemic; three of these patients were hemodynamically unstable. Abdominal pain was present in six. When performed, angiography (n=6) was diagnostic of a pseudoaneurysm; computed tomography (n=7) showed a pseudoaneurysm in two and a pseudocyst in five. Endoscopy (n=8) revealed blood issuing from the ampullary papilla in two patients. Operative management (n=6) involved distal pancreatectomy, pancreatoduodenectomy, or total pancreatectomy in two patients each. Angiographic embolization was successful in one patient, but the other died from uncontrollable hemorrhage.
Hemosuccus pancreaticus is rare, but should be considered in patients with chronic pancreatitis and gastrointestinal bleeding. In the absence of pancreatitis-related indications for surgery, angiographic embolization can be definitive treatment. If there are pancreatitis-related indications for operation, angiographic embolization may allow an elective operative procedure based on structural changes of the pancreas. If embolization fails, pancreatic resection is usually required, often on an emergent basis.
胰源性腹水是上消化道出血的一种罕见形式,可并发于慢性胰腺炎,并带来重大的诊断和治疗难题。
介绍我们处理这种慢性胰腺炎潜在危及生命并发症的经验。
我们回顾了1976年至1997年间对组织学确诊的慢性胰腺炎并发胰源性腹水患者的治疗经验(包括手术治疗和血管造影栓塞治疗)。胰源性腹水的诊断基于临床表现、术前内镜及影像学检查、手术所见及病理评估。
在此期间,我们共治疗了8例胰源性腹水患者(占所有接受手术治疗的慢性胰腺炎患者的1.5%)。上消化道出血表现为呕血3例、便血3例,但所有患者近期均有黑便且贫血;其中3例患者血流动力学不稳定。6例患者有腹痛。血管造影(n = 6)检查时,诊断为假性动脉瘤;计算机断层扫描(n = 7)显示2例为假性动脉瘤,5例为假性囊肿。内镜检查(n = 8)发现2例患者乳头开口处有血液流出。手术治疗(n = 6)包括2例患者行胰体尾切除术、2例患者行胰十二指肠切除术、2例患者行全胰切除术。血管造影栓塞治疗1例成功,但另1例死于无法控制的出血。
胰源性腹水较为罕见,但慢性胰腺炎合并上消化道出血的患者应考虑此病。在没有与胰腺炎相关的手术指征时,血管造影栓塞可作为确定性治疗。如果有与胰腺炎相关的手术指征,血管造影栓塞可使基于胰腺结构改变的择期手术成为可能。如果栓塞失败,通常需要行胰腺切除术,且往往是急诊手术。